Artemisinin Market Size, Share, Growth, and Industry Analysis by Type (Extraction From Artemisia Annua, Semisynthetic Artemisinin) by Application (Antimalarial Injections, Antimalarial Tablets), and Regional Forecast to 020352

ARTEMISININ MARKET REPORT OVERVIEW

The global Artemisinin Market size estimated at USD 129.6 million in 2026 and is projected to reach USD 672.76 million by 2035, growing at a CAGR of 20% from 2026 to 2035.

Artemisinin is a drug used for the treatment of malaria as well as parasitic worm infections. It is effective drug for malaria treatment caused by plasmodium falciparum, which is a highly prevalent cause for the disease. Malaria, as a disease is caused by the bite of anopheles mosquitos that transmit malaria causing pathogens in its saliva. Artemisinin and its derivatives kill parasites quickly and also simultaneously eliminate them from body to provide residual protection against reinfection. In comparison to standard treatment, ACT treatment of patients admitted in hospitals, with imported uncomplicated jungle fever, caused by reducing number of days spent in hospital, resulted in faster parasite clearance with lower severity in infections, increasing its preference of usage.

Participants are fixing their efforts on encouraging R&D. Technological development are supporting the regional market growth. Companies need to stay updated with varying market trends and develop products that meet rising consumer needs. Companies coming up with advanced technological solutions for firming their positions.

• 

  Download Free sample to learn more about this report.

COVID-19 IMPACT

"Pandemic Affected The Market Due To Unexpected Disruptions In The Sectors"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic had a significant impact on the market. As worldwide attention shifted toward handling the pandemic, malaria prevention and treatment programs were suggestively interrupted. Manufacturing postponements, supply chain disruptions, and labour scarcities further impacted the obtainability of both raw materials and finished products.

LATEST TRENDS

"Use Of Innovative Products To Boost The Market Growth"

Technological upgrading and improvement will further enhance the presentation of the product, allowing it to obtain a varied range of requests in the market. Technological advancement will improve performance and propel the market growth. Technological development with high demand is increasingly setting a force to increase the productivity. Some players focus on product improvement to meet consumer requirements and likings. Constant upgrading in manufacturing of products is anticipated to stimulate product demand.

• 

  Download Free sample to learn more about this report.

ARTEMISININ MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into Extraction From Artemisia Annua, Semisynthetic Artemisinin

• Extraction From Artemisia Annua: Extraction from Artemisia annua is the traditional and most extensively used method. This method is cost-effective in regions with appropriate climates but is vulnerable to farming risks, climate change, and price instability.

• Semisynthetic Artemisinin: Semisynthetic Artemisinin developed through biotechnology, comprises the use of hereditarily engineered yeast or chemical synthesis. This method offers reliable quality, constant supply, and scalability, making it perfect for large-scale medicinal making.

By Application Analysis

According to application, the market can be segmented into Antimalarial Injections, Antimalarial Tablets

• Antimalarial Injections: Antimalarial Injections, characteristically in the form of intravenous artesunate, are used for the dealing of severe or complex malaria. They offer quick action, making them vital in emergency settings such as hospitals and clinics.

• Antimalarial Tablets: Antimalarial tablets, mainly artemisinin-based combination therapies, are the most frequently used form of dealing for uncomplicated malaria. They are perfect for outpatient and mass handling programs due to ease of use, low cost, and high efficiency. Tablets are vibrant in national malaria control methods and are distributed through both public and private healthcare systems.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

"Rising Prevalence of Malaria To Boost The Market Growth"

Artemisinin demand is the determined burden of malaria, artemisinin and its derivatives, particularly in the form of artemisinin-based combination therapies, are measured the frontline dealing for plasmodium falciparum malaria. As worldwide health agencies endure to line up malaria extermination, demand for artemisinin remains sturdy.

"Technological Advancement and Innovation To Upsurge The Market"

Technological advancements and innovation activate unique revenue augmenting opportunity which will upsurge the Artemisinin Market growth. Growing investment in research and development activities and growing awareness about benefits are expected to deliver profitable opportunities for the market. New manufacturing techniques mostly semi-synthetic and bacterial synthesis methods have developed as sustainable substitutes to traditional removal from Artemisia annua.

Restraining Factor

"Raw Material Dependence and Price Volatility To Hamper The Market Growth"

Traditional artemisinin manufacturing depends on the cultivation of Artemisia annua, which is issue to periodic variations, temperature variability, and farming uncertainties. This leads to unstable pricing, affecting the cost-effectiveness of artemisinin-based products and discouraging constant investment.

Opportunity

"Strategic Public-Private Partnerships To Create Opportunity in the Market"

Collaborations between research institutions, medicinal companies, and governments can quicken the growth of next-generation artemisinin derivatives and alternate delivery systems, such as long-acting injectables or paediatric preparations, improving both effectiveness and access.

Challenge

"Regulatory Barriers Could Be a Major Challenge "

Fluctuating regulatory frameworks across countries can pose a barricade to market entry, particularly for innovative formulations or making methods. Navigating international drug approval procedures can be time-consuming and costly for pharmaceutical producers.

• 

  Download Free sampleto learn more about this report.

ARTEMISININ MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East and Africa.

• North America

North America is also a hub for biotechnological advancements, particularly in semi-synthetic artemisinin production using genetically engineered microorganisms. The U.S. is home to world-leading biotech firms, universities, and research investigating alternative uses for artemisinin which motivate the Artemisinin Market share.

• Asia

The Asia-Pacific region is the core of the global Artemisinin Market, both as a major producer and key consumer. The region’s diverse landscape includes malaria-endemic zones as well as pharmaceutical hubs, making it central to the Artemisinin Market’s overall dynamics.

• Europe

Europe, with its well-established pharmaceutical industry, is a significant player in drug formulation, manufacturing, and worldwide supply. Malaria occurrence in Europe is closely non-existent, with only occasional cases associated to travellers.

KEY INDUSTRY PLAYERS

"Key Players Focus On Partnerships To Gain Competitive Advantage"

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and increasing market share by merger, partnerships and others. Key players are motivated to introduce new innovative products. They are spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market. The market changes are dynamic such as market expansion, partnership and merger. The collective efforts of these major players expressively impact the competitive landscape and future path of the market.

List of Market Players Profiled

• Sanofi (France)
• Guangxi xiancaotang (China)
• Guilin Pharmaceutical (China)
• Kerui nanhai (China)
• Novanat Bioresource (China)

INDUSTRIAL DEVELOPMENT

November 2021:   Sanofi S.A. acquired Kadmon Holdings, Inc. through this acquisition, the firm will fulfil its commitment for supporting individuals facing health issues.

REPORT COVERAGE

The report provides scrutiny and information according to market sectors. Business overview, financial overview, product portfolio, new project launch, recent development enquiry are the factors included in the profile. The report incorporates completely examined and appraised evidence of the noticeable players and their position in the market by methods for various descriptive tools. The report covers national and regional level market size and forecast. The report gives businesses the facility to research new prospect in many areas. The report shows to be an operational tool that players can use to gain a competitive superiority over their opponents and ensure lasting achievement in the market.